0000899243-21-014280.txt : 20210331 0000899243-21-014280.hdr.sgml : 20210331 20210331201701 ACCESSION NUMBER: 0000899243-21-014280 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210324 FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brandenberger Ralph CENTRAL INDEX KEY: 0001853197 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 21795489 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-582-4923 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-03-24 0 0001787400 Nkarta, Inc. NKTX 0001853197 Brandenberger Ralph C/O NKARTA, INC. 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr. VP, Technical Operations Stock Option (right to buy) 0.41 2028-07-18 Common Stock 8727 D Stock Option (right to buy) 4.77 2029-05-10 Common Stock 10405 D Stock Option (right to buy) 3.89 2029-09-05 Common Stock 52287 D Stock Option (right to buy) 3.89 2029-09-05 Common Stock 34858 D Stock Option (right to buy) 18.00 2030-07-08 Common Stock 18480 D Stock Option (right to buy) 18.00 2030-07-08 Common Stock 17710 D Stock Option (right to buy) 54.89 2031-01-07 Common Stock 30000 D The option is vested and exercisable as to 6,271 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. The option is vested and exercisable as to 5,675 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. The option is vested and exercisable as to 18,334 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. The option is vested and exercisable as to 4,678 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. The option is vested and exercisable as to 2,480 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. The option is vested and exercisable as to 2,376 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 9, 2024. The option is vested and exercisable as to 1,250 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on January 8, 2025. /s/ Alicia Hager, Attorney-in-Fact for Ralph Brandenberger 2021-03-31 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

      The undersigned hereby constitutes and appoints each of Paul Hastings,
Chief Executive Officer of Nkarta, Inc., a Delaware corporation (the "Company"),
Nadir Mahmood, Chief Financial and Business Officer of the Company, and Alicia
Hager, Chief Legal Officer of the Company, the undersigned's true and lawful
attorney-in-fact to:

          1   execute for and on behalf of the undersigned, in the undersigned's
              capacity as an officer and/or director of the Company, Forms 3, 4,
              and 5 in accordance with Section 16(a) of the Securities Exchange
              Act of 1934, as amended and the rules thereunder (the "Exchange
              Act"), and/or authenticating documents pursuant to the rules
              governing the SEC's EDGAR Filer Management and application
              thereto;

          2   do and perform any and all acts for and on behalf of the
              undersigned which may be necessary or desirable to complete and
              execute any such Form 3, 4, or 5, complete and execute any
              amendment or amendments thereto, and timely file such form with
              the United States Securities and Exchange Commission and any stock
              exchange or similar authority; and

          3   take any other action of any type whatsoever in connection with
              the foregoing which, in the opinion of such attorney-in-fact, may
              be of benefit to, in the best interest of, or legally required by,
              the undersigned, it being understood that the documents executed
              by such attorney-in-fact on behalf of the undersigned pursuant to
              this Power of Attorney shall be in such form and shall contain
              such terms and conditions as such attorney-in-fact may approve in
              such attorney-in-fact's discretion.

      The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.

      The undersigned acknowledges that:

          1   neither the Company nor the foregoing attorney-in-fact assumes (i)
              any liability for the undersigned's responsibility to comply with
              the requirement of the Exchange Act, (ii) any liability of the
              undersigned for any failure to comply with such requirements or
              (iii) any obligation or liability of the undersigned for profit
              disgorgement under Section 16(b) of the Exchange Act; and

          2   this Power of Attorney does not relieve the undersigned from
              responsibility for compliance with the undersigned's obligations
              under the Exchange Act, including without limitation the reporting
              requirements under Section 16 of the Exchange Act.

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company
unless earlier revoked by the undersigned in a signed writing delivered to each
attorney-in-fact.

                 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.]


       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 29th day of March, 2021.

                                  /s/ R. Brandenberger
                                 ---------------------
                                 RALPH BRANDENBERGER